Results 1 to 10 of about 222,948 (152)

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea [PDF]

The Korean Journal of Internal Medicine
Background/Aims The model for end-stage liver disease (MELD) serves as an indicator for short-term mortality among patients diagnosed with liver cirrhosis (LC) and is used to prioritize patients for liver transplantation.
Jeong Han Kim, Yong Joon Cho, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo   +4 more
doaj   +4 more sources

Association of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomesCentral MessagePerspective [PDF]

JTCVS Open
Objective: We assessed the Model for End-Stage Liver Disease score in patients with mild-moderate scores to predict perioperative outcomes in patients undergoing cardiac surgery.
Tom Liu, MD, MS, Zhanlin Chen, BS, MS, Ryan C. Jacobs, MD, MS, Charles D. Logan, MD, MS, Beth Whippo, MSN, RN, Seokyung An, PhD, Patrick M. McCarthy, MD, Christopher K. Mehta, MD   +7 more
doaj   +2 more sources

The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study. [PDF]

Hepatol Commun, 2023
Background: The Model for End-stage Liver Disease (MELD) 3.0 yields high prognostic performance for patients with end-stage liver disease (ESLD). However, its prognostic performance for patients with alcohol-related liver disease (ARLD) has limited results.
Duan F, Liu C, Zhai H, Quan M, Cheng J, Yang S.   +5 more
europepmc   +3 more sources

Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region. [PDF]

Hepatology, 2021
Background and Aims The United Network for Organ Sharing’s Model for End‐Stage Liver Disease (UNOS‐MELD) score is the basis of liver allocation in the Eurotransplant region. It was constructed 20 years ago in a small US cohort and has remained unchanged ever since.
Goudsmit BFJ, Putter H, Tushuizen ME, Vogelaar S, Pirenne J, Alwayn IPJ, van Hoek B, Braat AE.   +7 more
europepmc   +6 more sources

Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis [PDF]

Medicina
Background and Objectives: The Model for End-Stage Liver Disease (MELD) score has widely been used for mortality prediction in liver cirrhosis (LC) patients and transplantation allocation. There have been recent modifications of MELD scores, such as MELD-
Seung-Kang Yoo, Jeong-Han Kim, Won-Hyeok Choe, So-Young Kwon   +3 more
doaj   +2 more sources

The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients

Frontiers in Medicine, 2022
Little is known about the shift of lymphocytes under the condition of the model for end-stage liver disease score and the follow-up period. Then, we detected the peripheral blood from liver transplant recipients by flow cytometry and compared the results.
Fei Pan, Shuang Cao, Xian-Liang Li, Ya-nan Jia, Ruo-lin Wang, Qiang He, Ji-Qiao Zhu   +6 more
doaj   +3 more sources

Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score [PDF]

Anesthesia and Pain Medicine, 2023
The mortality scoring systems for patients with end-stage liver disease have evolved from the Child-Turcotte-Pugh score to the model for end-stage liver disease (MELD) score, affecting the wait list for liver allocation.
Yang-Hoon Chung, Jaewoong Jung, Sang Hyun Kim   +2 more
doaj   +2 more sources

Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes [PDF]

Transplantation Direct, 2022
Background. Model for end-stage liver disease (MELD) exception criteria for portopulmonary hypertension (POPH) were created to prioritize patients for liver transplant before POPH progression.
Kathryn T. del Valle, MD, Michael J. Krowka, MD, Julie K. Heimbach, MD, Timucin Taner, MD, PhD, Hilary M. DuBrock, MD   +4 more
doaj   +2 more sources

Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation. [PDF]

Eur J Gastroenterol Hepatol, 2021
Objectives Model for End-Stage Liver Disease (MELD) alone and with sodium (MELD-Na) have decreasing predictive capacity as trends in liver disease evolve. We sought to combine transient elastography (TE) with MELD-Na to improve its predictive ability. Methods This is a retrospective
Trivedi HD, Danford CJ, Iriana S, Ochoa-Allemant P, Rourke M, Yang KC, Curry MP, Lai M.   +7 more
europepmc   +3 more sources

Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure [PDF]

Biomedicines
Introduction: Heart failure (HF) remains a leading cause of morbidity and hospitalization among elderly patients. Therefore, identifying reliable prognostic indicators is crucial for improving clinical outcomes in this population.
Michał Jurkiewicz, Wioletta Szczurek-Wasilewicz, Michał Skrzypek, Jacek J. Jóźwiak, Mariusz Gąsior, Bożena Szyguła-Jurkiewicz   +5 more
doaj   +2 more sources